De Novo Truncating Variants in ZNF865 Cause a Novel Neurodevelopmental Disorder
American Journal of Medical Genetics Part A · 2026
DOI: 10.1002/ajmg.a.64242 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Samuel M Bradbrook und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Alberta Children's Hospital, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Genetic Predisposition to Disease, Intellectual Disability, Neurodevelopmental Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, Clinical Translational Core (CTC) of the Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center (IDDRC), National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
Abstract (Originalsprache)
Despite significant knowledge advances in recent decades, the role of most protein‐coding genes in human disease remains incompletely understood. Exome sequencing continues to improve our understanding by elucidating novel genotype–phenotype associations. Across multiple healthcare centers, either exome or genome sequencing was performed in 18 patients with shared features of global developmental delay, hypotonia, and dysmorphisms. De novo, truncating variants in ZNF865 were identified in all 18 patients, with all but one clustered toward the C‐terminus. Four variants were seen more than once in unrelated patients. No disease‐causing variants were identified in other genes that would explain the patients' phenotypes. Little is known of the function of ZNF865, which belongs to the poly‐zinc finger family of proteins that contain a large array of tandem C2H2 zinc finger DNA binding domains. Our findings suggest that protein‐truncating variants in this gene lead to intellectual disability with a recognizable phenotypic pattern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Alberta Children's Hospital, Calgary, Alberta, Canada.
- Department of Genetics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
- HC Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
- Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- Department of Neurology, Odense University Hospital, and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Genetics, Oakland Medical Center, Oakland, California, USA.
ORCID-Profile: Samuel M Bradbrook, Melissa T Carter, Julian Martinez-Agosto, Sacha Schutz, Gaetan Lesca, Jonathan Levy
Förderung
- NHGRI NIH HHS
- Clinical Translational Core (CTC) of the Baylor College of Medicine (BCM) Intellectual and Developmental Disabilities Research Center (IDDRC)
- National Institute of Neurological Disorders and Stroke of the National Institutes of Health
- NICHD NIH HHS
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Intellectual and Developmental Disabilities Research Center
Zitieren
APA
Bradbrook, S. M., Graham, G., Carter, M. T., Kibaek, M., Fagerberg, C., Larsen, M. J., Dawson, K., Meuter, C., Pepler, A., Besnard, T., Vincent, M., Isidor, B., Bezieau, S., Cogne, B., Bjørgo, K., Amundsen, S. S., Courtin, T., Emrick, L., Rosenfeld, J. A., …, & Marcadier, J. (2026). De Novo Truncating Variants in ZNF865 Cause a Novel Neurodevelopmental Disorder. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64242
Vancouver
Bradbrook SM, Graham G, Carter MT, Kibaek M, Fagerberg C, Larsen MJ, et al. De Novo Truncating Variants in ZNF865 Cause a Novel Neurodevelopmental Disorder. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.64242
BibTeX
@article{Bradbrook2026,
author = {Bradbrook, Samuel M and Graham, Gail and Carter, Melissa T and Kibaek, Maria and Fagerberg, Christina and Larsen, Martin J and Dawson, Katherine and Meuter, Cheryl and Pepler, Alexander and Besnard, Thomas and Vincent, Marie and Isidor, Bertrand and Bezieau, Stephane and Cogne, Benjamin and Bjørgo, Kathrine and Amundsen, Silja Svanstrøm and Courtin, Thomas and Emrick, Lisa and Rosenfeld, Jill A and Weisz-Hubshman, Monika and Undiagnosed Diseases Network, Undiagnosed Diseases Network and Mak, Bryan C and Martinez-Agosto, Julian and Heulin, Mathilde and Morin, Gilles and Keren, Boris and Schutz, Sacha and Monin, Pauline and Pujalte, Mathilde and Januel, Louis and Lesca, Gaetan and Valence, Marie-Noëlle Bonnet-Dupeyron and Margot, Henri and Levy, Jonathan and Iovino, Emmanuela and Isidori, Federica and Pippucci, Tommaso and Montanari, Francesca and Bell, Lauren and Burton, Jennifer and Torti, Erin and Wentzensen, Ingrid M and Marcadier, Julien},
title = {De Novo Truncating Variants in ZNF865 Cause a Novel Neurodevelopmental Disorder},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
doi = {10.1002/ajmg.a.64242}
}
EUVIMED